Characterization of changes in total body composition for patients with head and neck cancer undergoing chemoradiotherapy using dual-energy x-ray absorptiometry
- 21 November 2013
- journal article
- research article
- Published by Wiley in Head & Neck
- Vol. 36 (9) , 1356-1362
Abstract
Background Patients with head and neck cancer experience significant weight loss secondary to concurrent chemoradiotherapy (CCRT). Using dual‐energy X‐ray absorptiometry (DEXA) scans, we characterize total body composition changes during and after CCRT in order to develop novel clinical care models that will improve the patient's quality of life (QOL). Methods Sixty DEXA scans were obtained from 12 patients undergoing CCRT for locally advanced squamous cell head and neck cancer. DEXAs were performed at baseline, during treatment, completion of CCRT, and then 1 and 2 months posttreatment. Results Mean weight loss by treatment end was 9.5 kg (10.2%; p = .0002). On average, lean body mass (LBM) decreased 10.2% (p = .001), and fat body mass (FBM) decreased 11.1% (p = .001) during CCRT. LBM began to normalize after completion of treatment, whereas FBM continued to decline. Conclusion Substantial loss of muscle and FBM occurs in patients undergoing CCRT for head and neck cancer. To prevent long‐term disability and QOL decline after curative CCRT, clinical care interventions incorporating aggressive nutrition/exercise counseling are needed. © 2013 Wiley Periodicals, Inc. Head Neck 36: 1356–1362, 2014Keywords
This publication has 31 references indexed in Scilit:
- Importance of Lean Body Mass in the Oncologic PatientNutrition in Clinical Practice, 2012
- Body Composition, Symptoms, and Survival in Advanced Cancer Patients Referred to a Phase I ServicePLOS ONE, 2012
- Gastrostomy tube placement and use in patients with head and neck cancerHead & Neck, 2011
- Definition and classification of cancer cachexia: an international consensusThe Lancet Oncology, 2011
- A descriptive review of the factors contributing to nutritional compromise in patients with head and neck cancerSupportive Care in Cancer, 2009
- Longitudinal oncology registry of head and neck carcinoma (LORHAN®): initial supportive care findingsSupportive Care in Cancer, 2009
- Changes in body mass, energy balance, physical function, and inflammatory state in patients with locally advanced head and neck cancer treated with concurrent chemoradiation after low‐dose induction chemotherapyHead & Neck, 2007
- Body weight and composition changes in ovarian cancer patients during adjuvant chemotherapyGynecologic Oncology, 2006
- Body composition and time course changes in regional distribution of fat and lean tissue in unselected cancer patients on palliative care—Correlations with food intake, metabolism, exercise capacity, and hormonesCancer, 2005
- A phase III randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer: Preliminary resultsHead & Neck, 1997